The Medical Letter on Drugs and Therapeutics
FROM
ISSUE 1293
ISSUE 1293
August 25, 2008
Issue 1293
Subscribers: Log in to read full issue. Not a subscriber? Subscribe or purchase issue.
Aliskiren/Hydrochlorothiazide (Tekturna HCT) for Hypertension
August 25, 2008 (Issue: 1293)
Aliskiren (Tekturna - Novartis), the first direct renin inhibitor for treatment of hypertension, has been approved for use in a fixed-dose combination with the diuretic hydrochlorothiazide (Tekturna HCT - Novartis). Many angiotensin-converting enzyme...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.